Gilbert Halley E bought ARQT
November 20, 2025 · Form 4 insider transaction
Gilbert Halley E bought 12,220 shares of Arcutis Biotherapeutics, Inc. at $7.51 per share, a transaction worth $91.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,220
Price
$7.51
Total value
$91.8K
InsiderGilbert Halley E
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 20, 2025
Filing dateNovember 21, 2025
Shares owned after38,655
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.